- Ranirestat
-
- $399.00 / 2mg
-
2024-11-13
- CAS:147254-64-6
- Min. Order:
- Purity: 96.10%
- Supply Ability: 10g
|
| (3R)-2'-(4-Bromo-2-fluorobenzyl)spiro[pyrrolidine-3,4'-1'H-pyrrolo[1,2-a]pyrazine]-1',2,3',5(2'H)-tetraone Basic information |
Product Name: | (3R)-2'-(4-Bromo-2-fluorobenzyl)spiro[pyrrolidine-3,4'-1'H-pyrrolo[1,2-a]pyrazine]-1',2,3',5(2'H)-tetraone | Synonyms: | (3R)-2'-(4-Bromo-2-fluorobenzyl)spiro[pyrrolidine-3,4'-1'H-pyrrolo[1,2-a]pyrazine]-1',2,3',5(2'H)-tetraone;Ranirestat;AS 3201;AS-3201;Spiro[pyrrolidine-3,4'(1'H)-pyrrolo[1,2-a]pyrazine]-1',2,3',5(2'H)-tetrone,2'-[(4-broMo-2-fluorophenyl)Methyl]-, (3R)-;Ranirestat,AS-3201;Raniestat;AS-3201; SX-3201 | CAS: | 147254-64-6 | MF: | C17H11BrFN3O4 | MW: | 420.19 | EINECS: | | Product Categories: | | Mol File: | 147254-64-6.mol | ![(3R)-2'-(4-Bromo-2-fluorobenzyl)spiro[pyrrolidine-3,4'-1'H-pyrrolo[1,2-a]pyrazine]-1',2,3',5(2'H)-tetraone Structure](CAS/20180808/GIF/147254-64-6.gif) |
| (3R)-2'-(4-Bromo-2-fluorobenzyl)spiro[pyrrolidine-3,4'-1'H-pyrrolo[1,2-a]pyrazine]-1',2,3',5(2'H)-tetraone Chemical Properties |
Melting point | 192-193℃ | Boiling point | 702.7±60.0 °C(Predicted) | density | 1.83 | storage temp. | Sealed in dry,Store in freezer, under -20°C | solubility | DMSO: 20mg/mL, clear | form | Solid | pka | 10.48±0.20(Predicted) | color | Off-white to pink | optical activity | [α]/D -5 to -10°, c =1.0 in methanol |
| (3R)-2'-(4-Bromo-2-fluorobenzyl)spiro[pyrrolidine-3,4'-1'H-pyrrolo[1,2-a]pyrazine]-1',2,3',5(2'H)-tetraone Usage And Synthesis |
Uses | Ranirestat is an aldose reductase inhibitor used for the treatment of diabetic sensorimotor polyneuropathy. | Biological Activity | Ranirest at (AS-3201) is an aldose reductase (AR) inhibitor. Aldose reductase is a rate-limiting enzyme in the conversion of D-glucose to fructose via D-sorbitol. Ranirest at has been implicated in diabetic complications (cataract formation, retinopathy, neuropathy, nephropathy). Ranirest at prevents sorbitol accumulation and is thus hoped to be effective in the remedy of diabetic neuropathy. |
| (3R)-2'-(4-Bromo-2-fluorobenzyl)spiro[pyrrolidine-3,4'-1'H-pyrrolo[1,2-a]pyrazine]-1',2,3',5(2'H)-tetraone Preparation Products And Raw materials |
|